Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 22 Nov 2021 |
10 | TM-P(SUBSEQUENT PROPRIETOR BY WAY OF ASSIGNMENT OR TRANSFER OF A SINGLE MARK) | 09 Jul 2024 |
11 | TM-P(ALTER OR SUBSTITUTE OF ADDRESS FOR SERVICE IN INDIA) | 07 Sep 2024 |
2 | Reply to Exam Report (MIS-R) | 29 Dec 2021 |
3 | Reply to Exam Report (MIS-R) | 10 Jan 2022 |
4 | Documents in support of Show cause Hearing (SCH) | 30 Oct 2022 |
5 | Authorization Letter | 12 Nov 2022 |
6 | Authorization Letter | 14 Nov 2022 |
7 | Authorization Letter | 29 May 2023 |
8 | Journal Copy | 16 Nov 2023 |
9 | Certificate | 01 Feb 2024 |
1 | EXAMINATION REPORT | 12645033 | 14 Dec 2021 | |
2 | Hearing Notice (Show Cause) | 14197964 | 11 Oct 2022 | |
3 | Hearing Notice (Show Cause) | 15166503 | 28 Apr 2023 | |
4 | Tribunal Accepted Notice for : 5218593 | 15765700 | 6097095 | 04 Aug 2023 |
Biopanib was applied on 22 November 2021.
Trademark application was filed by BIOCON BIOLOGICS.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Biopanib is 5218593.
Trademark attorney of the Biopanib is Puthran & Associates.
Biopanib is a WORD as per IP India data.